This compound is an active pharmaceutical ingredient reference standard, structurally characterized as a quinoline derivative with a dihydroxyheptenoic acid side chain and a cyclopropyl group. It is provided for analytical and quality control applications in pharmaceutical manufacturing.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1159631-31-8
(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
active pharmaceutical ingredient reference standard
Icomucret
active pharmaceutical ingredient reference standard
Carboxy-nifedipine
active pharmaceutical ingredient reference standard
Cinacalcet Related Compound C
active pharmaceutical ingredient reference standard
(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-6-[(3,5-Dimethyl-1-adamantyl)amino]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
pharmaceutical intermediate or impurity
All-trans-Retinal
Vitamin A aldehyde metabolite
Pevonedistat Hydrochloride
NAE inhibitor antineoplastic agent
Insulin-aspart
active pharmaceutical ingredient
(Z,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
VGYFMXBACGZSIL-DBBWNDPISA-N
C1CC1C2=NC3=CC=CC=C3C(=C2/C=C\[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F